Evidence map›Paper›PMID 8710753›Full record

ArticlePharmaceutical research1996

Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system.

M Yoshida, R I Mahato, K Kawabata, Y Takakura, M Hashida

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Dysopsonin activity of serum DNA-binding proteins favorable for gene delivery.The Journal of pharmacology and experimental therapeutics · 2010
    Article
  5. Article
  6. Article
  7. Article
  8. Pharmacokinetics of plasmid DNA in the rat.Pharmaceutical research · 2001
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

M YoshidaDepartment of Drug Delivery Research, Faculty of Pharmaceutical Sciences, Kyoto University, Japan.
R I Mahato
K Kawabata
Y Takakura
M Hashida
Kyoto University · JPKyoto Pharmaceutical University · JPKyoto University of Education · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo define the hepatic uptake mechanism of a plasmid DNA, we quantitated the uptake of pCAT (plasmid DNA encoding chloramphenicol acetyltransferase reporter gene fused to simian virus 40 promoter), a model plasmid, after a single pass through the perfused rat liver using albumin- and erythrocyte-free Krebs-Ringer bicarbonate buffer (pH 7.4).

methods[32P]pCAT was introduced momentarily into this system from the portal vein as a bolus input or constant infusion mode, and the outflow patterns and hepatic uptake were evaluated using statistical moment analysis.

resultsThe venous outflow samples had electrophoretic bands similar to that of the standard pCAT, suggesting that the plasmid is fairly stable in the perfusate during liver perfusion. In bolus experiments, pCAT was largely taken up by the liver and the uptake was decreased with increase in injected dose. Statistical moment analysis against outflow patterns demonstrated that the apparent volume of distribution of pCAT was greater than that of human serum albumin, indicating a significant reversible interaction with the tissues. The results of collagenase perfusion experiments suggest that the hepatic accumulation of pCAT occurred preferentially in the nonparenchymal cells (NPC). The amount of total recovery in the liver decreased substantially by preceding administration of polyinosinic acid, dextran sulfate, succinylated bovine serum albumin, but not by polycytidylic acid. This suggests that pCAT is taken up by the liver via scavenger receptors for polyanions on the NPC. In constant infusion experiments, the presence of 2,4-dinitrophenol and NH4Cl caused a significant increase in the outflow concentration of [32P]pCAT and decrease by half in the total hepatic recovery than that of plasmid DNA administered alone, suggesting that plasmid DNA may undergo internalization by the NPC.

conclusionsThe liver plays an important role in the elimination of plasmid DNA and a successful delivery system will be required to avoid its recognition by the scavenger receptors on the liver NPC.

Indexed as

4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic AcidAnimalsBuffersChloramphenicol O-AcetyltransferaseDextran SulfateDNADrug Delivery SystemsElectrophoresis, Agar GelGene Expression Regulation, EnzymologicGenes, ReporterGenetic TherapyHumansInjections, IntravenousInosine MonophosphateLiverMale4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic AcidBuffersChloramphenicol O-AcetyltransferaseDextran SulfateDNAInosine MonophosphatePolymersSerum Albumin

Identifiers

PMID8710753
OpenAlexW1570307043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.